[go: up one dir, main page]

MA34598B1 - Procédés et compositions pour traiter le cancer du poumon - Google Patents

Procédés et compositions pour traiter le cancer du poumon

Info

Publication number
MA34598B1
MA34598B1 MA35800A MA35800A MA34598B1 MA 34598 B1 MA34598 B1 MA 34598B1 MA 35800 A MA35800 A MA 35800A MA 35800 A MA35800 A MA 35800A MA 34598 B1 MA34598 B1 MA 34598B1
Authority
MA
Morocco
Prior art keywords
compositions
lung cancer
methods
treating lung
treating
Prior art date
Application number
MA35800A
Other languages
English (en)
Inventor
Sheng-Yung Liu
San-Bao Hwang
Wu-Che Wen
Original Assignee
Golden Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corp filed Critical Golden Biotechnology Corp
Publication of MA34598B1 publication Critical patent/MA34598B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/02—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains containing only carbon and hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/10—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by etherified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385—Saturated compounds containing a keto group being part of a ring
    • C07C49/517—Saturated compounds containing a keto group being part of a ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des procédés et des compositions pour traiter le cancer du poumon avec des composés de cyclohexénone.
MA35800A 2010-09-20 2011-04-15 Procédés et compositions pour traiter le cancer du poumon MA34598B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
TW99131844 2010-09-20
TW99145853 2010-12-24
US13/070,308 US8309611B2 (en) 2010-09-20 2011-03-23 Methods and compositions for treating lung cancer
PCT/US2011/032785 WO2012039793A1 (fr) 2010-09-20 2011-04-15 Procédés et compositions pour traiter le cancer du poumon

Publications (1)

Publication Number Publication Date
MA34598B1 true MA34598B1 (fr) 2013-10-02

Family

ID=45818282

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35800A MA34598B1 (fr) 2010-09-20 2011-04-15 Procédés et compositions pour traiter le cancer du poumon

Country Status (19)

Country Link
US (1) US8309611B2 (fr)
EP (1) EP2655309A4 (fr)
JP (1) JP2014504256A (fr)
KR (2) KR20150014534A (fr)
CN (1) CN103221373A (fr)
AR (1) AR083026A1 (fr)
AU (1) AU2011306068B2 (fr)
BR (1) BR112013006567A2 (fr)
CA (1) CA2809762C (fr)
CO (1) CO6700836A2 (fr)
EA (1) EA201370071A1 (fr)
IL (1) IL225262A0 (fr)
MA (1) MA34598B1 (fr)
MX (1) MX2011007763A (fr)
MY (1) MY157341A (fr)
PH (1) PH12013500529A1 (fr)
SG (1) SG188610A1 (fr)
TW (1) TWI483718B (fr)
WO (1) WO2012039793A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309611B2 (en) 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
CN103570531A (zh) * 2012-07-25 2014-02-12 丽丰实业股份有限公司 樟芝菌丝体的化合物及其用途
JP6407876B2 (ja) * 2012-11-21 2018-10-17 ゴールデン バイオテクノロジー コーポレーション 神経変性疾患を処置する方法および組成物
TWI597061B (zh) * 2013-02-20 2017-09-01 國鼎生物科技股份有限公司 治療白血病之方法及組成物
US20140274979A1 (en) * 2013-03-13 2014-09-18 Golden Biotechnology Corporation Method for the treatment of fatty liver disease
JP5908002B2 (ja) * 2013-03-20 2016-04-26 卉菱 曽 ベニクスノキタケに含まれる化合物及びその用途
TWI583376B (zh) * 2013-03-20 2017-05-21 Hui-Ling Zeng Compounds isolated from Antelroxicus and their use
US9480723B2 (en) * 2013-05-02 2016-11-01 Kingland Property Corporation, Ltd. Method of preparing an extract of Antrodia cinnamomea having an elevated antcin C and zhankuic C content
CN104211627A (zh) * 2013-05-29 2014-12-17 曾卉菱 牛樟芝化合物、萃取物及其用途
CN104706682B (zh) * 2013-12-12 2018-01-30 富裔实业股份有限公司 一种中草药萃取物及其用于制备肺癌药物的用途
CN105237365B (zh) * 2014-07-09 2017-09-08 台湾利得生物科技股份有限公司 樟芝固态培养菌丝体的萃取物及其应用
WO2016011130A1 (fr) * 2014-07-17 2016-01-21 National Taiwan University Compositions et procédés pour la préparation de composés 4-oxy-2-cyclohexénone et 6-oxy-2-cyclohexénone
JP6593856B2 (ja) * 2014-09-03 2019-10-23 台灣利得生物科技股▲ふん▼有限公司 抗肺癌細胞転移用組成物およびその製造方法
MY173104A (en) * 2014-12-30 2019-12-26 Oneness Biotech Co Ltd Compounds from antrodia camphorata, method for preparing the same and use thereof
EP3454866A4 (fr) * 2016-05-13 2020-01-08 Golden Biotechnology Corporation Méthodes et compositions pour traiter le cancer du poumon non à petites cellules à stade avancé
US11406605B2 (en) * 2017-12-20 2022-08-09 Golden Biotechnology Corporation Therapeutic compositions for treating pancreatic cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4861560B2 (ja) * 2001-02-19 2012-01-25 株式会社明治 糖尿病合併症治療剤
US20070116787A1 (en) * 2005-11-21 2007-05-24 Chih-Jung Yao Cancer treatment
TW200829234A (en) 2007-01-08 2008-07-16 Golden Biotechnology Corp Antrodia camphorata isophorone extract
CN101225066B (zh) 2007-01-18 2010-09-22 国鼎生物科技股份有限公司 牛樟芝的环己烯酮萃取物
TW200918498A (en) 2007-10-19 2009-05-01 Golden Biotechnology Corp Novel compound isolated from Antrodia camphorate extracts
CN101417934B (zh) * 2007-10-24 2012-04-18 国鼎生物科技股份有限公司 分离自牛樟芝萃取物的化合物
TW201102075A (en) * 2009-07-09 2011-01-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of pancreatic cancer
TW201109013A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone chemical compounds of Antrodia cinnamomea for suppressing the growth of the Lymphoma tumor cell
TWI383790B (zh) * 2009-09-09 2013-02-01 Golden Biotechnology Corp Used to inhibit the growth of oral cancer cells of the cattle Antrodylcyclohexenone compounds
TWI394566B (zh) * 2009-09-09 2013-05-01 Golden Biotechnology Corp Used to inhibit the growth of ovarian cancer tumor cells of the cattle camphor cyclohexene ketone compounds
TWI383791B (zh) * 2009-09-09 2013-02-01 Golden Biotechnology Corp Used to inhibit the growth of gastric cancer tumor cells of the male antler ketone compounds
TW201109023A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of colorectal cancer
TW201109014A (en) * 2009-09-09 2011-03-16 Golden Biotechnology Corp Cyclohexenone compound of Antrodia cinnomomea that suppresses growth of tumor cell of skin cancer
EP2329816B1 (fr) * 2009-11-26 2016-04-13 National Taiwan University Substance active anti-cancer à partir de camphorata antrodia, procédé de préparation associé et utilisation correspondante
US8309611B2 (en) 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer

Also Published As

Publication number Publication date
CA2809762C (fr) 2016-02-02
US20120071426A1 (en) 2012-03-22
AR083026A1 (es) 2013-01-23
TW201212906A (en) 2012-04-01
EP2655309A4 (fr) 2014-09-03
AU2011306068B2 (en) 2014-08-07
IL225262A0 (en) 2013-06-27
SG188610A1 (en) 2013-04-30
KR20130061746A (ko) 2013-06-11
BR112013006567A2 (pt) 2017-10-24
CA2809762A1 (fr) 2012-03-29
EP2655309A1 (fr) 2013-10-30
EA201370071A1 (ru) 2013-10-30
MY157341A (en) 2016-05-31
MX2011007763A (es) 2012-07-04
PH12013500529A1 (en) 2017-08-09
US8309611B2 (en) 2012-11-13
KR20150014534A (ko) 2015-02-06
TWI483718B (zh) 2015-05-11
WO2012039793A1 (fr) 2012-03-29
AU2011306068A1 (en) 2013-05-02
JP2014504256A (ja) 2014-02-20
CO6700836A2 (es) 2013-06-28
CN103221373A (zh) 2013-07-24

Similar Documents

Publication Publication Date Title
MA34598B1 (fr) Procédés et compositions pour traiter le cancer du poumon
PH12017501298A1 (en) Pesticidal compositions and processes related thereto
MX345909B (es) Anticuerpos anti-fgfr3 y métodos que los utilizan.
EA201171367A1 (ru) Винилиндазолильные соединения
EP2569434A4 (fr) Compositions et méthodes de traitement de la leucémie
PH12013502230A1 (en) Multispecific antibodies
MY163852A (en) Amidophenoxyindazoles useful as inhibitors of c-met.
EA201390145A1 (ru) Конъюгаты, частицы, композиции и связанные с ними способы
PH12013502686A1 (en) Pesticidal compositions and processes related thereto
MX356107B (es) Histidil-arnt sintetasas para tratar enfermedades autoinmunes e inflamatorias.
MX2018005265A (es) Composiciones pesticidas y procesos relacionados a las mismas.
PH12014500930A1 (en) Pesticidal compositions and processes related thereto
PH12014500910A1 (en) Pesticidal compositions and processes related thereto
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
JO3755B1 (ar) تركيبات تستوستيرون
WO2012166626A8 (fr) Réactifs et procédés pour traiter une maladie dentaire
WO2013106747A3 (fr) Méthodes et compositions pour le traitement et le diagnostic du cancer de la thyroïde
MX2015006337A (es) Metodos y composiciones para tratar enfermedades neurodegenerativas.
WO2013023151A3 (fr) Compositions et méthodes de traitement de maladie cœliaque
MX2014006187A (es) Composiciones y metodos para el analisis de cancer de prostata.
IN2014DN00254A (fr)
MX2013014488A (es) Metodos y composiciones para tratar el cancer cerebral.
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
IN2012DN01971A (fr)
MX2013002111A (es) Metodos y composiciones para el tratamiento de metastasis del cancer.